ブデソニドエアロゾルの世界市場インサイト・予測(~2025年)

【英語タイトル】Global Budesonide Aerosol Market Insights, Forecast to 2025

QYResearchが出版した調査資料(QYR20FB08615)・商品コード:QYR20FB08615
・発行会社(調査会社):QYResearch
・発行日:2019年12月(※2024年版があります。お問い合わせください)
・ページ数:151
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界のブデソニドエアロゾル市場について調査・分析し、以下の構成でお届け致します。ブデソニドエアロゾルの種類別には、50ug / 200スプレー、100ug / 200スプレー、200ug / 100スプレー、その他に、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別ブデソニドエアロゾル売上データ
・地域別ブデソニドエアロゾル市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別ブデソニドエアロゾル市場規模:50ug / 200スプレー、100ug / 200スプレー、200ug / 100スプレー、その他
・用途別ブデソニドエアロゾル市場規模:病院、診療所、その他
・主要メーカーの企業情報:AstraZeneca、Pfizer、Teva、Cipla、Novartis、Mylan、Abbott、Takeda、Boehringer Ingelheim、Allgen Pharmaceuticals、Squibb、Sandoz、Shimadzu Corp、Manus Aktteva Biopharma LLP、Skyepharma、Shanghai Sine Pharmaceutical、Lunan Better Pharmaceutical、Wellcome Australia Ltd、Synmosa Biopharma Corporation、Chiesi Farmaceutici S.p.A
・ブデソニドエアロゾルの市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...
【レポートの概要】

The global Budesonide Aerosol market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Budesonide Aerosol market based on company, product type, end user and key regions.
This report studies the global market size of Budesonide Aerosol in key regions like North America, Europe, China and Japan, focuses on the consumption of Budesonide Aerosol in these regions.
This research report categorizes the global Budesonide Aerosol market by top players/brands, region, type and end user. This report also studies the global Budesonide Aerosol market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Pfizer
Teva
Cipla
Novartis
Mylan
Abbott
Takeda
Boehringer Ingelheim
Allgen Pharmaceuticals
Squibb
Sandoz
Shimadzu Corp
Manus Aktteva Biopharma LLP
Skyepharma
Shanghai Sine Pharmaceutical
Lunan Better Pharmaceutical
Wellcome Australia Ltd
Synmosa Biopharma Corporation
Chiesi Farmaceutici S.p.A

Budesonide Aerosol market size by Type
50ug/200 Spray
100ug/200 Spray
200ug/100 Spray
Other

Budesonide Aerosol market size by Applications
Hospitals
Clinics
Other

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Budesonide Aerosol market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Budesonide Aerosol market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Budesonide Aerosol companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Budesonide Aerosol submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Budesonide Aerosol are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Budesonide Aerosol market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 Budesonide Aerosol Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Budesonide Aerosol Market Size Growth Rate by Type
1.4.2 50ug/200 Spray
1.4.3 100ug/200 Spray
1.4.4 200ug/100 Spray
1.4.5 Other
1.5 Market by Application
1.5.1 Global Budesonide Aerosol Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Budesonide Aerosol Market Size
2.1.1 Global Budesonide Aerosol Revenue 2014-2025
2.1.2 Global Budesonide Aerosol Sales 2014-2025
2.2 Budesonide Aerosol Growth Rate by Regions
2.2.1 Global Budesonide Aerosol Sales by Regions
2.2.2 Global Budesonide Aerosol Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Budesonide Aerosol Sales by Manufacturers
3.1.1 Budesonide Aerosol Sales by Manufacturers
3.1.2 Budesonide Aerosol Sales Market Share by Manufacturers
3.2 Budesonide Aerosol Revenue by Manufacturers
3.2.1 Budesonide Aerosol Revenue by Manufacturers (2014-2019)
3.2.2 Budesonide Aerosol Revenue Share by Manufacturers (2014-2019)
3.3 Budesonide Aerosol Price by Manufacturers
3.4 Budesonide Aerosol Manufacturing Base Distribution, Product Types
3.4.1 Budesonide Aerosol Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Budesonide Aerosol Product Type
3.4.3 Date of International Manufacturers Enter into Budesonide Aerosol Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Budesonide Aerosol Sales by Type
4.2 Global Budesonide Aerosol Revenue by Type
4.3 Budesonide Aerosol Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Budesonide Aerosol Breakdown Data by Application

6 North America
6.1 North America Budesonide Aerosol by Country
6.1.1 North America Budesonide Aerosol Sales by Country
6.1.2 North America Budesonide Aerosol Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Budesonide Aerosol by Type
6.3 North America Budesonide Aerosol by Application

7 Europe
7.1 Europe Budesonide Aerosol by Country
7.1.1 Europe Budesonide Aerosol Sales by Country
7.1.2 Europe Budesonide Aerosol Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Budesonide Aerosol by Type
7.3 Europe Budesonide Aerosol by Application

8 Asia Pacific
8.1 Asia Pacific Budesonide Aerosol by Region
8.1.1 Asia Pacific Budesonide Aerosol Sales by Region
8.1.2 Asia Pacific Budesonide Aerosol Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Budesonide Aerosol by Type
8.3 Asia Pacific Budesonide Aerosol by Application

9 Central & South America
9.1 Central & South America Budesonide Aerosol by Country
9.1.1 Central & South America Budesonide Aerosol Sales by Country
9.1.2 Central & South America Budesonide Aerosol Revenue by Country
9.1.3 Brazil
9.2 Central & South America Budesonide Aerosol by Type
9.3 Central & South America Budesonide Aerosol by Application

10 Middle East and Africa
10.1 Middle East and Africa Budesonide Aerosol by Country
10.1.1 Middle East and Africa Budesonide Aerosol Sales by Country
10.1.2 Middle East and Africa Budesonide Aerosol Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Budesonide Aerosol by Type
10.3 Middle East and Africa Budesonide Aerosol by Application

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Budesonide Aerosol Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Budesonide Aerosol Products Offered
11.2.5 Pfizer Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Business Overview
11.3.3 Teva Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Budesonide Aerosol Products Offered
11.3.5 Teva Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Company Business Overview
11.4.3 Cipla Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cipla Budesonide Aerosol Products Offered
11.4.5 Cipla Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Company Business Overview
11.5.3 Novartis Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Novartis Budesonide Aerosol Products Offered
11.5.5 Novartis Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Company Business Overview
11.6.3 Mylan Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Mylan Budesonide Aerosol Products Offered
11.6.5 Mylan Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Company Business Overview
11.7.3 Abbott Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abbott Budesonide Aerosol Products Offered
11.7.5 Abbott Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Company Business Overview
11.8.3 Takeda Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Takeda Budesonide Aerosol Products Offered
11.8.5 Takeda Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Company Business Overview
11.9.3 Boehringer Ingelheim Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Boehringer Ingelheim Budesonide Aerosol Products Offered
11.9.5 Boehringer Ingelheim Recent Development
11.10 Allgen Pharmaceuticals
11.10.1 Allgen Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Allgen Pharmaceuticals Budesonide Aerosol Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Allgen Pharmaceuticals Budesonide Aerosol Products Offered
11.10.5 Allgen Pharmaceuticals Recent Development
11.11 Squibb
11.12 Sandoz
11.13 Shimadzu Corp
11.14 Manus Aktteva Biopharma LLP
11.15 Skyepharma
11.16 Shanghai Sine Pharmaceutical
11.17 Lunan Better Pharmaceutical
11.18 Wellcome Australia Ltd
11.19 Synmosa Biopharma Corporation
11.20 Chiesi Farmaceutici S.p.A

12 Future Forecast
12.1 Budesonide Aerosol Market Forecast by Regions
12.1.1 Global Budesonide Aerosol Sales Forecast by Regions 2019-2025
12.1.2 Global Budesonide Aerosol Revenue Forecast by Regions 2019-2025
12.2 Budesonide Aerosol Market Forecast by Type
12.2.1 Global Budesonide Aerosol Sales Forecast by Type 2019-2025
12.2.2 Global Budesonide Aerosol Revenue Forecast by Type 2019-2025
12.3 Budesonide Aerosol Market Forecast by Application
12.4 North America Budesonide Aerosol Forecast
12.5 Europe Budesonide Aerosol Forecast
12.6 Asia Pacific Budesonide Aerosol Forecast
12.7 Central & South America Budesonide Aerosol Forecast
12.8 Middle East and Africa Budesonide Aerosol Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Budesonide Aerosol Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



【掲載企業】

AstraZeneca、Pfizer、Teva、Cipla、Novartis、Mylan、Abbott、Takeda、Boehringer Ingelheim、Allgen Pharmaceuticals、Squibb、Sandoz、Shimadzu Corp、Manus Aktteva Biopharma LLP、Skyepharma、Shanghai Sine Pharmaceutical、Lunan Better Pharmaceutical、Wellcome Australia Ltd、Synmosa Biopharma Corporation、Chiesi Farmaceutici S.p.A

★調査レポート[ブデソニドエアロゾルの世界市場インサイト・予測(~2025年)] (コード:QYR20FB08615)販売に関する免責事項を必ずご確認ください。
★調査レポート[ブデソニドエアロゾルの世界市場インサイト・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆